Ajax-Loading

Eli Lilly and Company - Current Deferred Revenue

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Current-Deferred-Revenue" stands at 3.88 Billion United States Dollars as of 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 96.15 percent compared to the value the year prior.
The 1 year change in percent is 96.15.
The 3 year change in percent is -52.85.
The 5 year change in percent is -37.05.
The 10 year change in percent is -7.15.

The Serie's long term average value is 5.01 Billion United States Dollars. It's latest available value, on 09/30/2024, is 22.56 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2012, to it's latest available value, on 09/30/2024, is +249.16%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 09/30/2024, is -73.27%.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11
LogoNovartis AG - Current Deferred Revenue255,096,620,580.91